A product of independent beta probabilities dose escalation design for dual-agent phase I trials. (2015)
Attributed to:
Large-scale integrative studies of risk factors in coronary heart disease: from discovery to application
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/sim.6434
PubMed Identifier: 25630638
Publication URI: http://europepmc.org/abstract/MED/25630638
Type: Journal Article/Review
Volume: 34
Parent Publication: Statistics in medicine
Issue: 8
ISSN: 0277-6715